Skip to main content
Eurostyle Collection Lisboa Table Lamp by Gilt <img src="https://chart.googleapis.com/chart?cht=qr&chs=200x200&chl=https%3A%2F%2Fapi.shopstyle.com%2Faction%2FapiVisitRetailer%3Fid%3D687775003%26pid%3Duid1456-40284116-11%26utm_content%3Dqr-code">

ALL ABOUT MS Diagnosis of the disease (Part 7)

Diagnosis of the disease

MS is not easy to diagnose. There is no specific test that could be diagnosed unambiguously, as there is no symptom that is specifically characteristic of that disease, or that only occurs therein. Diagnosis of MS must begin with a detailed history of the disease, followed by a complete physical examination, not only neurological, but also all other somatic systems. It is necessary to make certain laboratory tests to exclude possible other causes of symptoms.

In addition, in order to diagnose MS, it is necessary, in the case of a relapse-remitent form, that there are at least two neurological disorders that reflect the demyelination period separated by a period of at least 30 days. Or, in the case of a primarily progressive form, there must be a slow progression of symptoms over a period of at least 6 months.
Diagnosis of MS can be set only on the basis of clinical data and physical examination, but usually, for the diagnosis and initiation of therapy, additional methods are used in diagnostics. These are magnetic resonance (MRI) of the brain and spinal cord, evoked brain potentials, and analysis of cerebrospinal fluid.

Magnetic resonance is a widely used method in diagnosing MS. In the MRI, the demyelinating area in the brain and spinal cord is seen as a white spot. The magnetic resonance of the lower parts of the spinal cord (thoracic and lumbar spine) is rarely done because it often does not produce good results, because its interpretation is difficult due to numerous artifacts. This non-invasive method can track the progression of the disease in detail.

It should be pointed out that MS diagnosis can not be established solely on the basis of MRI, as its results can often refer to other diseases of the central nervous system.
Evoked potentials measure the electrical activity of certain regions of the brain in response to the stimulation of certain groups of nerves. This method is used as an ancillary diagnostic tool and allows demyelination to be detected which otherwise would not be possible to observe. In our conditions, the visual, auditory and sensory potentials are most often used to assess the passage of electrical impulses through appropriate functional paths.



In the analysis of cerebrospinal fluid, there are data on the existence of chronic inflammation of the central nervous system. Cerebrospinal fluid is tested for the existence of oligoclonal bands representing immunoglobulins found in 90-95% of people with MS (but also in persons with some other disorders) and a sign of the existence of an immune response within the central nervous system. Together with MRI and clinical data, the presence of oligoclonal tape helps to definitively diagnose MS. The cerebrospinal fluid is obtained by the lumbar puncture procedure. The analysis of cerebrospinal fluid also helps to exclude the possibility of some viral infection and other diseases that cause neurological symptoms similar to MS.

Comments

Popular posts from this blog

ALL ABOUT MS Treatment (Part 9)

ALL ABOUT MS  Treatment (Part 9) Glatiramer acetate (Copaxone) This drug has similar effects and indications as interferon beta but a slightly different mechanism of action. It is applied at a dose of 20 mg, daily, subcutaneously. Side effects are also somewhat different, and include skin changes at the drug site and transient and short-term feeling of tightness in the chest with heart palpitations and a sense of lack of air. Natalizumab (Tysabri) This medicine is administered intravenously once a month. It works by preventing the immune system's entry into the brain and thus reducing the inflammatory (inflammatory) effect of immune cells on the nerve cells. Clinical trials have shown that natalizumab significantly reduces the incidence of attacks in the relapse form of MS, but in three patients it has caused a rare, but often fatal, brain disease. After this, the drug was withdrawn from the market, but in 2006 it was returned because of its positive effects o...

ALL ABOUT MS Treatment (Part 8)

Treatment Since research has shown that MS is an autoimmune disease, two basic approaches, immunosuppression (weakening of the immune response of the organism) and immunomodulation (changing the immune response) are used in the treatment. Numerous studies have shown that in the treatment of MS, the following drugs have success: interferon beta (betaferon, rebif, avonex), glatiramer acetate (copaxone), natalizumab (tysabri), mitoxantrone (novantrone) and some other cytostatics. Interferon beta Interferon beta is a protein that is a natural component of the human organism and is created by the cells of our immune system during defense reactions to external agents, primarily viruses. However, the most important effect this protein has is the so-called. Immunomodulatory effect: interferon beta promotes processes that mitigate the effects and slow down the ankle of multiple sclerosis, while the opposite inhibits it. The exact mechanism by which the interferon beta acts the...

ALL ABOUT MS Symptoms of MS (Part 4)

Urinary disorders About one-third of patients have sphincter disorders: an overwhelming need for urinary incontinence, which can sometimes be accompanied by frequent urination (so-called polacizuria), difficulty in urinating, retention (complete inability to urinate) and incontinence (loss of control over the process urinating, so that the urinary bladder empties reluctantly and unexpectedly). Urinary disorders can be accompanied by constipation and incontinence of the stool and impotence. Urinary disorders are very disturbing disorders, which significantly affect the quality of life, personal, professional and social functioning of the patients. Urinary disorders in MS are very common and occur in approximately 96% of patients with MS after 10 years of illness. Urinary disorders can occur at any time during the course of the disease, even at its inception (in about 2% of patients). Some researchers believe that patients in whom the disease begins with problems in the...